Literature DB >> 28278308

Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis.

Ketan Dhatariya1.   

Abstract

Diabetic ketoacidosis (DKA) remains a common medical emergency. Over the last few years, new national guidelines have changed the focus in managing the condition from being glucose-centered to ketone-centered. With the advent of advancing technology and the increasing use of hand-held, point-of-care ketone meters, greater emphasis is placed on making treatment decisions based on these readings. Furthermore, recent warnings about euglycemic DKA occurring in people with diabetes using sodium-glucose co-transporter 2 (SGLT-2) inhibitors urge clinicians to inform their patients of this condition and possible testing options. This review describes the reasons for a change in treating DKA, and outlines the benefits and limitations of using ketone readings, in particular highlighting the difference between urine and capillary readings.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28278308      PMCID: PMC5734222          DOI: 10.1900/RDS.2016.13.217

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  59 in total

1.  National study of U.S. emergency department visits with diabetic ketoacidosis, 1993-2003.

Authors:  Adit A Ginde; Andrea J Pelletier; Carlos A Camargo
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

2.  Note on the sodium nitro-prusside reaction for acetone.

Authors:  A C Rothera
Journal:  J Physiol       Date:  1908-12-15       Impact factor: 5.182

3.  Clinical utility of Abbott Precision Xceed Pro® ketone meter in diabetic patients.

Authors:  Hoi-Ying Elsie Yu; Michael Agus; Mark D Kellogg
Journal:  Pediatr Diabetes       Date:  2011-03-29       Impact factor: 4.866

4.  The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice.

Authors:  T M Wallace; N M Meston; S G Gardner; D R Matthews
Journal:  Diabet Med       Date:  2001-08       Impact factor: 4.359

5.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.

Authors:  Yehuda Handelsman; Robert R Henry; Zachary T Bloomgarden; Sam Dagogo-Jack; Ralph A DeFronzo; Daniel Einhorn; Ele Ferrannini; Vivian A Fonseca; Alan J Garber; George Grunberger; Derek LeRoith; Guillermo E Umpierrez; Matthew R Weir
Journal:  Endocr Pract       Date:  2016-06-01       Impact factor: 3.443

6.  Diabetic ketoacidosis in Denmark Incidence and mortality estimated from public health registries.

Authors:  Otto M Henriksen; Michael E Røder; Julie B Prahl; Ole Lander Svendsen
Journal:  Diabetes Res Clin Pract       Date:  2006-09-07       Impact factor: 5.602

7.  Beta-hydroxybutirate levels as a determinant for the success of diabetic ketoacidosis management.

Authors:  Ika Prasetya Wijaya; Pradana Soewondo; Djoko Widodo; Aru W Sudoyo
Journal:  Acta Med Indones       Date:  2004 Apr-Jun

Review 8.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

9.  Diabetic ketoacidosis in an adolescent and young adult population in the UK in 2014: a national survey comparison of management in paediatric and adult settings.

Authors:  J A Edge; I Nunney; K K Dhatariya
Journal:  Diabet Med       Date:  2016-02-12       Impact factor: 4.359

10.  Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.

Authors:  L M B Laffel; K Wentzell; C Loughlin; A Tovar; K Moltz; S Brink
Journal:  Diabet Med       Date:  2006-03       Impact factor: 4.359

View more
  22 in total

1.  Evaluation of Nova StatStrip and FreeStyle Precision Pro blood ketone tests using 3-hydroxybutyrate doped samples.

Authors:  Johanna Helmersson-Karlqvist; Kristina Höög Hammarström; Kicki Palmberg; Carolina Backman-Johansson
Journal:  J Clin Lab Anal       Date:  2019-02-27       Impact factor: 2.352

Review 2.  [Diabetic emergencies : Hypoglycemia, ketoacidotic and hyperglycemic hyperosmolar nonketotic coma].

Authors:  H Kalscheuer; G Serfling; S Schmid; H Lehnert
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

3.  Modeling Ketogenesis for Use in Pediatric Diabetes Simulation.

Authors:  Catherina Pinnaro; Gary E Christensen; Vanessa Curtis
Journal:  J Diabetes Sci Technol       Date:  2019-10-14

4.  Serum ketone body measurement in patients with diabetic ketoacidosis.

Authors:  Tomonao Hirobata; Hidefumi Inaba; Yosuke Kaido; Daisuke Kosugi; Saya Itoh; Takaaki Matsuoka; Gen Inoue
Journal:  Diabetol Int       Date:  2022-04-13

5.  Interference of ketone bodies on laboratory creatinine measurement in children with DKA: a call for change in testing practices.

Authors:  Damian Feldman-Kiss; Dailin Li; Richard Cleve; Graham Sinclair; Joshua A Dubland; Li Wang
Journal:  Pediatr Nephrol       Date:  2021-11-10       Impact factor: 3.651

6.  Long-term glycemic control and prevention of diabetes complications in vivo using oleic acid-grafted-chitosan‑zinc-insulin complexes incorporated in thermosensitive copolymer.

Authors:  Divya Sharma; Jagdish Singh
Journal:  J Control Release       Date:  2020-04-10       Impact factor: 9.776

7.  Continuous Ketone Monitoring: A New Paradigm for Physiologic Monitoring.

Authors:  Jennifer Y Zhang; Trisha Shang; Suneil K Koliwad; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-04-09

8.  The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review.

Authors:  Lauren S Dewsbury; Chai K Lim; Genevieve Z Steiner
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

9.  Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis.

Authors:  Eric S Kilpatrick; Alexandra E Butler; Linda Ostlundh; Stephen L Atkin; David B Sacks
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

Review 10.  Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA).

Authors:  Ketan K Dhatariya; Priyathama Vellanki
Journal:  Curr Diab Rep       Date:  2017-05       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.